As of Apr 20
| -0.075 / -3.09%|
The 3 analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 2.25. The median estimate represents a +112.77% increase from the last price of 2.35.
The current consensus among 3 polled investment analysts is to Buy stock in AcelRx Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.